- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01471912
Elongation of Foveal Tissue After Macular Hole Surgery
Asymmetric Elongation of Foveal Tissue After Macular Hole Surgery and Its Impact on Metamorphopsia
In our experience, elongation of foveal tissue after macular hole surgery which was undetectable by conventional time-domain optical coherence tomography was often observed on spectral-domain optical coherence tomography images. Elongation of tissues inevitably induces some degree of disorganization of tissue microstructure.
The purpose of the present study was to evaluate elongation profile of foveal tissue after macular hole surgery and to investigate its impact on visual acuity and metamorphopsia.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 135-710
- Samsung Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who were diagnosed with idiopathic macular hole
Exclusion Criteria:
- traumatic macular hole
- evidence of ocular inflammation, diabetic retinopathy, hypertensive retinopathy, and retinal vasculitis, media opacity that would influence visual acuity or preclude acquisition of clear spectral domain optical coherence tomography images
- presence of cataract judged to affect visual function, -6.0 diopters or more of spherical equivalent, prominent staphyloma
- history of intraocular surgery other than uncomplicated cataract surgery, other ocular diseases that may influence the macular microstructure or visual function
- patients with indistinct intraretinal structure on spectral domain optical coherence tomography images
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in the inter-outer plexiform layer distance
Time Frame: first postoperative visit, 1 month, 2 months, and 6 months after macular hole surgery
|
the spectral domain optical coherence tomography scannings were performed at first postoperative visit, 1 month, 2 months, and 6 months after macular hole surgery.
The inter-outer plexiform layer distance was measured based on optical coherence tomography images at defined time points
|
first postoperative visit, 1 month, 2 months, and 6 months after macular hole surgery
|
Changes in best-corrected visual acuity
Time Frame: first postoperative visit, 2 months, and 6 months after macular hole surgery
|
Best-corrected visual acuity was measured using early treatment diabetic retinopathy study chart at defined time points
|
first postoperative visit, 2 months, and 6 months after macular hole surgery
|
Changes in degree of metamorphopsia
Time Frame: first postoperative visit, 2 months, and 6 months after macular hole surgery
|
The degree of metamorphopsia was measured using Metamorphopsia-chart at defined time points
|
first postoperative visit, 2 months, and 6 months after macular hole surgery
|
Degree of percent asymmetric elongation on the same plane
Time Frame: at 6 months postoperative
|
The horizontal percent asymmetry was calculated as (nasal distance - temporal distance)/(nasal distance + temporal distance).
The vertical percent asymmetry was also calculated as (superior distance - inferior distance)/ (superior distance + inferior distance.
|
at 6 months postoperative
|
Degree of horizontal-vertical percent asymmetry
Time Frame: at 6 months postoperative
|
The percent asymmetry was calculated as (horizontal inter-outer plexiform layer distance - vertical inter-outer plexiform layer distance)/(horizontal inter-outer plexiform layer distance + vertical inter-outer plexiform layer distance).
|
at 6 months postoperative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-10-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Macular Holes
-
Helse Stavanger HFMcGill University; Haukeland University Hospital; Royal Liverpool University... and other collaboratorsNot yet recruitingMacular Holes
-
Oriental Neurosurgery Evidence-Based-Study TeamRecruiting
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
Tianjin Medical UniversityActive, not recruiting
-
Second Affiliated Hospital, School of Medicine,...Unknown
-
Federal University of São PauloUnknown
-
Kyorin UniversityCompleted
-
Fayoum UniversityResearch Institute of Ophthalmology, EgyptRecruiting
-
Minia UniversityRecruiting
-
Faculty Hospital Kralovske VinohradyCharles University, Czech RepublicRecruiting
Clinical Trials on pars plana vitrectomy and fluid gas exchange
-
Centre Hospitalier Universitaire DijonCompletedPostoperative Complications | Intraocular Pressure,France
-
Ain Shams UniversityNot yet recruitingRhegmatogenous Retinal Detachment
-
Benha UniversityRecruiting
-
University of Kansas Medical CenterRecruiting
-
PharmaBio CorporationRecruitingMyopic Chorioretinal AtrophyJapan
-
Ospedale Policlinico San MartinoRecruitingRetinal Detachment | PArs Plana Vitrectomy | Silicone Oil Droplets on Intraocular LensItaly
-
Ospedale Policlinico San MartinoRecruiting
-
Omer Othman AbdullahTerminated
-
Minia UniversityCompleted
-
AllerganCompletedVitrectomyUnited States